BACKGROUND The relationship between hepatitis B surface antigen(HBsAg)-positive carrier status and liver cancer has been extensively studied.However,the epigenetic changes that occur during progression from HBsAg-posi...BACKGROUND The relationship between hepatitis B surface antigen(HBsAg)-positive carrier status and liver cancer has been extensively studied.However,the epigenetic changes that occur during progression from HBsAg-positive carrier status or cirrhosis to liver cancer are unknown.The epigenetic modification of DNA hydroxymethylation is critical in tumor development.Further,5-hydroxymethylcytosine(5hmC)is an important base for DNA demethylation and epigenetic regulation.It is also involved in the assembly of chromosomes and the regulation of gene expression.However,the mechanism of action of 5hmC in HBsAgpositive carriers or patients with cirrhosis who develop liver cancer has not been fully elucidated.AIM To investigate the possible epigenetic mechanism of HBsAg-positive carriers and hepatocellular carcinoma(HCC)progression from cirrhosis.METHODS Forty HBsAg-positive carriers,forty patients with liver cirrhosis,and forty patients with liver cancer admitted to the First People's Hospital of Yongkang between March 2020 and November 2021 were selected as participants.Free DNA was extracted using a cf-DNA kit.cfDNA was extracted by 5hmC DNA sequencing for principal component analysis,the expression profiles of the three groups of samples were detected,and the differentially expressed genes(DEGs)modified by hydroxymethylation were screened.Bioinformatic analysis was used to enrich DEGs,such as in biological pathways.RESULTS A total of 16455 hydroxymethylated genes were identified.Sequencing results showed that 32 genes had significant 5hmC modification differences between HBsAg carriers and liver cancer patients,of which 30 were upregulated and 2 downregulated in patients with HCC compared with HBsAg-positive carriers.Significant 5hmC modification differences between liver cirrhosis and liver cancer patients were identified in 20 genes,of which 17 were upregulated and 3 were downregulated in patients with HCC compared with those with cirrhosis.These genes may have potential loci that are undiscovered or unelucidated,which contribute to the development and progression of liver cancer.Analysis of gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes showed that the major signaling pathways involved in the differential genes were biliary secretion and insulin secretion.The analysis of protein interactions showed that the important genes in the protein-protein interaction network were phosphoenolpyruvate carboxykinase and solute carrier family 2.CONCLUSION The occurrence and development of liver cancer involves multiple genes and pathways,which may be potential targets for preventing hepatitis B carriers from developing liver cancer.展开更多
为了进一步研究透明质酸酶的过敏活性,利用昆虫杆状病毒成功地表达了黄唇蜾蠃蜂Rhynchium brunneum蜂毒的透明质酸酶。根据已报道的胡蜂科透明质酸酶和抗原5基因的氨基酸保守序列,设计合成简并引物,利用反转录多聚酶链式反应(RT-PCR)技...为了进一步研究透明质酸酶的过敏活性,利用昆虫杆状病毒成功地表达了黄唇蜾蠃蜂Rhynchium brunneum蜂毒的透明质酸酶。根据已报道的胡蜂科透明质酸酶和抗原5基因的氨基酸保守序列,设计合成简并引物,利用反转录多聚酶链式反应(RT-PCR)技术扩增了黄唇蜾蠃蜂蜂毒透明质酸酶和抗原5的基因片段,利用RACE技术进一步获得了它们的全长基因(GenBank登录号分别为EU624135和EU624136)。按照过敏原的命名法则,分别命名为Rhy b 2和Rhy b 5。序列比对分析发现,这两个基因与胡蜂科的相应序列高度相似,说明对胡蜂蜂毒过敏的人群也可能对蜾蠃蜂蜂毒有交叉过敏反应。但进一步分析发现,黄唇蜾蠃蜂蜂毒透明质酸酶的B细胞决定表位显著不同,9个保守性氨基酸在蜾蠃蜂中仅保留了3个,而且缺乏两个关键的精氨酸;黄唇蜾蠃蜂蜂毒抗原5序列N端的二级结构和具有过敏活性的常见黄胡蜂Vespula vulgaris蜂毒的抗原5显著不同,有可能因此而缺失依赖其N端二级结构的B细胞决定表位。据此认为,蜾蠃蜂蜂毒透明质酸酶和抗原5很可能是天然弱化的过敏原,在过敏原特异性免疫治疗上具有潜在的应用价值。展开更多
基金Supported by Science and Technology Planning Project of Zhejiang Province,No.LGF20H160001.
文摘BACKGROUND The relationship between hepatitis B surface antigen(HBsAg)-positive carrier status and liver cancer has been extensively studied.However,the epigenetic changes that occur during progression from HBsAg-positive carrier status or cirrhosis to liver cancer are unknown.The epigenetic modification of DNA hydroxymethylation is critical in tumor development.Further,5-hydroxymethylcytosine(5hmC)is an important base for DNA demethylation and epigenetic regulation.It is also involved in the assembly of chromosomes and the regulation of gene expression.However,the mechanism of action of 5hmC in HBsAgpositive carriers or patients with cirrhosis who develop liver cancer has not been fully elucidated.AIM To investigate the possible epigenetic mechanism of HBsAg-positive carriers and hepatocellular carcinoma(HCC)progression from cirrhosis.METHODS Forty HBsAg-positive carriers,forty patients with liver cirrhosis,and forty patients with liver cancer admitted to the First People's Hospital of Yongkang between March 2020 and November 2021 were selected as participants.Free DNA was extracted using a cf-DNA kit.cfDNA was extracted by 5hmC DNA sequencing for principal component analysis,the expression profiles of the three groups of samples were detected,and the differentially expressed genes(DEGs)modified by hydroxymethylation were screened.Bioinformatic analysis was used to enrich DEGs,such as in biological pathways.RESULTS A total of 16455 hydroxymethylated genes were identified.Sequencing results showed that 32 genes had significant 5hmC modification differences between HBsAg carriers and liver cancer patients,of which 30 were upregulated and 2 downregulated in patients with HCC compared with HBsAg-positive carriers.Significant 5hmC modification differences between liver cirrhosis and liver cancer patients were identified in 20 genes,of which 17 were upregulated and 3 were downregulated in patients with HCC compared with those with cirrhosis.These genes may have potential loci that are undiscovered or unelucidated,which contribute to the development and progression of liver cancer.Analysis of gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes showed that the major signaling pathways involved in the differential genes were biliary secretion and insulin secretion.The analysis of protein interactions showed that the important genes in the protein-protein interaction network were phosphoenolpyruvate carboxykinase and solute carrier family 2.CONCLUSION The occurrence and development of liver cancer involves multiple genes and pathways,which may be potential targets for preventing hepatitis B carriers from developing liver cancer.
文摘为了进一步研究透明质酸酶的过敏活性,利用昆虫杆状病毒成功地表达了黄唇蜾蠃蜂Rhynchium brunneum蜂毒的透明质酸酶。根据已报道的胡蜂科透明质酸酶和抗原5基因的氨基酸保守序列,设计合成简并引物,利用反转录多聚酶链式反应(RT-PCR)技术扩增了黄唇蜾蠃蜂蜂毒透明质酸酶和抗原5的基因片段,利用RACE技术进一步获得了它们的全长基因(GenBank登录号分别为EU624135和EU624136)。按照过敏原的命名法则,分别命名为Rhy b 2和Rhy b 5。序列比对分析发现,这两个基因与胡蜂科的相应序列高度相似,说明对胡蜂蜂毒过敏的人群也可能对蜾蠃蜂蜂毒有交叉过敏反应。但进一步分析发现,黄唇蜾蠃蜂蜂毒透明质酸酶的B细胞决定表位显著不同,9个保守性氨基酸在蜾蠃蜂中仅保留了3个,而且缺乏两个关键的精氨酸;黄唇蜾蠃蜂蜂毒抗原5序列N端的二级结构和具有过敏活性的常见黄胡蜂Vespula vulgaris蜂毒的抗原5显著不同,有可能因此而缺失依赖其N端二级结构的B细胞决定表位。据此认为,蜾蠃蜂蜂毒透明质酸酶和抗原5很可能是天然弱化的过敏原,在过敏原特异性免疫治疗上具有潜在的应用价值。
